ACUPUNCTURE CHINA LIMITED
Opportunity 72/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Average employees | 100 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (17 events)Click to expand
- 2026-04-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-05-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-05-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-05-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-02-22📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-01-24📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-01-12➕DONG, Yunqiang appointeddirector
- 2023-01-12➖DONG, Yunqiang resigneddirector
- 2022-06-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-08📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2022-01-24📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-06-17📄accounts-with-accounts-type-dormantaccounts · AA
- 2020-01-28📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-01-14📄accounts-with-accounts-type-dormantaccounts · AA
- 2017-05-17🏢Company incorporatedAs ACUPUNCTURE CHINA LIMITED
- 2017-05-17➕MA, Yuping appointeddirector
- 2017-05-17📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Yuping Ma Individual · Chinese · DOB 09/1973 · age 53 | 75–100% | 75–100% | board controlsig. influence75-100% shares · 75-100% voting · board control · significant influence · trust interest · firm interest | 17/05/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · SO postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 365 ENHANCED LIMITED→ 16310761 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| A&B CORCORAN LTD→ 15486285 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| A&G PHILLIPS CONSULTANCY LIMITED→ 10179292 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AB DENT LIMITED→ 11038919 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AB EVENT MEDICAL SERVICES LIMITED→ 14966758 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABLAZE HEALTHCARE LIMITED→ 14351404 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ABSTREAM LIMITED→ 14039384 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ACHIEVE AESTHETICS LIMITED→ 14910395 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ACHIEVE CARE LTD→ 12467264 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ACOR LIMITED→ 14769944 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ACTION24 HEALTHCARE LTD→ 14900748 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADADEBO LTD→ 15654725 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.